- Condition: Angiotensin-converting Enzyme (ACE) Inhibitor-associated Angioedema
Interventions: Drug: HOE-140; Other: Placebo
Sponsors: Vanderbilt University; Vanderbilt University; University of California, San Diego; Massachusetts General Hospital; University of California, Los Angeles
Recruiting - verified April 2012 - Condition: Angioedema
Intervention: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
Sponsors: Bernstein, Jonathan A., M.D.; Bernstein, Jonathan A., M.D.; Dyax Corp.
Recruiting - verified March 2012 - Condition: Coronary Arteriosclerosis
Interventions: Drug: HOE 140; Drug: Aminocaproic Acid; Drug: Placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified July 2011 - Condition: Hyperlipidemia
Interventions: Drug: Tetraethylammonium (TEA); Drug: L-NMMA; Drug: Bradykinin; Drug: Nitroprusside; Drug: S-methyl-L-thiocitrulline (SMTC); Drug: Acetylcholine
Sponsors: Emory University; Emory University
Recruiting - verified May 2012
 |
Bradykinin Clinical Trials |
